NeOnc Technologies Holdings, Inc. Common Stock

NTHI

NeOnc Technologies Holdings, Inc. is a healthcare-focused company specializing in the development and commercialization of innovative diagnostic and therapeutic solutions for cancer. The company aims to leverage advanced technologies to improve cancer detection and treatment, providing targeted options to enhance patient outcomes.

$5.88 +0.02 (0.34%)
🚫 NeOnc Technologies Holdings, Inc. Common Stock does not pay dividends

Company News

NeOnc Technologies (Nasdaq: NTHI) to Host Investor Conference Call to Present Data Updates from Ongoing NEO100-1 Phase 1/2a Clinical Trial and Compassionate Use Program
GlobeNewswire Inc. • Neonc Technologies • November 7, 2025

NeOnc Technologies will host an investor conference call to present data updates from its ongoing Phase 1/2a NEO100-1 clinical trial, focusing on intranasal delivery of NEO100 for treating recurrent high-grade malignant glioma.

Related Companies

NetEase, inc.
NetEase, inc.
NTES
NETGEAR, Inc.
NETGEAR, Inc.
NTGR
Network-1 Technologies, Inc.
Network-1 Technologies, Inc.
NTIP
Northern Technologies International Corp.
Northern Technologies International Corp.
NTIC